(Q52365160)

30 April 2018

title

Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. (English)

1 reference

30 April 2018

1 reference

1

1 reference

30 April 2018

author name string

F Bendtsen

series ordinal

2

1 reference

30 April 2018

E Christensen

series ordinal

3

1 reference

30 April 2018

J H Henriksen

series ordinal

4

1 reference

30 April 2018

publication date

1 December 1994

1 reference

30 April 2018

published in

Journal of Hepatology

1 reference

30 April 2018

volume

21

1 reference

30 April 2018

issue

6

1 reference

30 April 2018

page(s)

940-946

1 reference

30 April 2018

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Portal pressure, presence of gastroesophageal varices and variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Prediction of variceal hemorrhage by esophageal endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Prognostic indicators in alcoholic cirrhotic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Circulating noradrenaline and central haemodynamics in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Reduced central blood volume in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Multivariate survival analysis using Cox's regression model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Can we predict the first variceal bleeding in the individual patient with cirrhosis and esophageal varices?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Vasodilatation associated with hepatocellular disease: relation to functional organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980599-9

7 January 2021

10.1016/S0168-8278(05)80599-9

Identifiers

DOI

1 reference

30 April 2018

PubMed ID

7699257

1 reference

30 April 2018